​

Foghorn Therapeutics Ownership | Who Owns Foghorn Therapeutics?

OverviewForecastRevenueFinancialsChart

Foghorn Therapeutics Ownership Summary

Foghorn Therapeutics is owned by 12.38% institutional investors, 22.63% insiders, and 64.98% retail investors. Flagship pioneering is the largest institutional shareholder, holding 20.25% of FHTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.82% of its assets in Foghorn Therapeutics shares.

FHTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockFoghorn Therapeutics12.38%22.63%64.98%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Flagship pioneering12.67M20.25%$59.82M
Fmr5.69M9.09%$26.86M
Bvf inc/il5.30M8.47%$25.03M
Raymond james & associates2.34M5.51%$13.45M
Deerfield management company, l.p. (series c)3.26M5.20%$15.37M
Blackrock1.55M3.64%$8.89M
Raymond james financial2.03M3.24%$9.58M
Blackrock funding, inc. /de2.03M3.24%$9.58M
Vanguard group1.75M2.79%$8.26M
Euclidean capital1.57M2.51%$7.43M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Flagship pioneering12.67M17.90%$59.82M
Birchview capital, lp310.93K1.20%$1.47M
Euclidean capital1.57M1.01%$7.43M
Bvf inc/il5.30M0.85%$25.03M
Deerfield management company, l.p. (series c)3.26M0.29%$15.37M
Dafna capital management186.72K0.22%$881.30K
Sio capital management121.67K0.16%$574.29K
Siren720.72K0.15%$3.40M
Alphabet500.90K0.14%$2.36M
Artal group720.72K0.11%$4.14M

Top Buyers

HolderShares% AssetsChange
Raymond james financial2.03M0.00%2.03M
Point72 asset management634.76K0.01%235.06K
Blackrock1.55M0.00%230.70K
Deerfield management company, l.p. (series c)3.26M0.29%227.63K
Blackrock funding, inc. /de2.03M0.00%217.91K

Top Sellers

HolderShares% AssetsChange
Fmr5.69M0.00%-644.26K
Driehaus capital management---568.47K
Perceptive advisors---544.00K
Colony group---215.69K
Invesco---56.04K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial2.03M0.00%2.03M$9.58M
Los angeles capital management15.85K0.00%15.85K$74.82K
Bnp paribas arbitrage, snc12.95K-12.95K$61.10K
China universal asset management11.79K0.01%11.79K$55.64K
Cubist systematic strategies10.89K0.00%10.89K$51.42K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-2.00
Nelson, van denburg & campbell wealth management group-3.00
Capital performance advisors llp-14.00
Group one trading-151.00
Visionpoint advisory group-210.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202436-55.00%7,752,816-80.62%120.30%22-46.34%2-89.47%
Sep 30, 2024809.59%39,996,0161.40%630.74%417.89%1918.75%
Jun 30, 2024735.80%39,443,56549.07%922.37%3835.71%16-11.11%
Mar 31, 20246916.95%26,459,8101.01%621.61%2816.67%185.88%
Dec 31, 202359-3.28%26,194,106-2.71%621.50%2426.32%17-10.53%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S2.68M4.82%26.32K
Fidelity Growth Compy Commingled Pl O2.62M4.73%-
Fidelity Growth Company Fund1.86M3.34%-38.10K
Vanguard Total Stock Mkt Idx Inv962.18K1.73%-
iShares Russell 2000 ETF624.00K1.12%-12.18K
Fidelity Growth Company K6568.14K1.02%-12.32K
Vanguard Institutional Extnd Mkt Idx Tr518.51K0.93%-
Fidelity Series Growth Company397.84K0.72%-19.18K
Fidelity Small Cap Index261.26K0.47%-1.01K
Fidelity Select Biotechnology197.25K0.35%-404.19K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 23, 2024Costa Carlos Chief People OfficerSell$8.72K
Sep 20, 2024Costa Carlos Chief People OfficerSell$358.99K
Sep 18, 2024Costa Carlos Chief People OfficerSell$116.32K
Sep 16, 2024Costa Carlos Chief People OfficerSell$4.00K
Sep 17, 2024Costa Carlos Chief People OfficerSell$103.13K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q4--
2024 Q3-6
2024 Q22-
2024 Q1-1

FHTX Ownership FAQ

Who Owns Foghorn Therapeutics?

Foghorn Therapeutics shareholders are primarily institutional investors at 12.38%, followed by 22.63% insiders and 64.99% retail investors. The average institutional ownership in Foghorn Therapeutics's industry, Biotech Stocks , is 69.02%, which Foghorn Therapeutics falls below.

Who owns the most shares of Foghorn Therapeutics?

Foghorn Therapeutics’s largest shareholders are Flagship pioneering (12.67M shares, 20.25%), Fmr (5.69M shares, 9.09%), and Bvf inc/il (5.3M shares, 8.47%). Together, they hold 37.80% of Foghorn Therapeutics’s total shares outstanding.

Does Blackrock own Foghorn Therapeutics?

Yes, BlackRock owns 3.64% of Foghorn Therapeutics, totaling 1.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.89M$. In the last quarter, BlackRock increased its holdings by 230.7K shares, a 17.54% change.

Who is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested, with 17.90% of its assets in 12.67M Foghorn Therapeutics shares, valued at 59.82M$.

Who is the top mutual fund holder of Foghorn Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Foghorn Therapeutics shares, with 4.82% of its total shares outstanding invested in 2.68M Foghorn Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools